Excellent- but not unexpected. Obviously Goldseeker has been wrong in his interpretation of GCDx and their goal to become a force in the Cancer Diagnostics market.
Question: How far reaching will Mr. Gartner's reach actually be?
Answer: All the way to India, China, and Europe via RXPC and its in-place network. Living, you have always been to quick to assume the most negative- adjust your biases a bit.
News 
Market Data 
Discover 
